Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omniscan Safety in Moderate Renal Insufficiency
NCT00908310Phase 4Completed
- Sponsor
- GE HealthCare
- Start
- May 2009
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadodiamide, sponsored by GE HealthCare. Started May 2009; status: completed.
02
Drugs
gadodiamide
Beyond the preview
Go deeper on NCT00908310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908310.